Alzheimer's disease (AD) is the most common form of dementia, affecting millions of people worldwide. Mutations in the genes PSEN1, PSEN2 or APP are known to cause familial forms of AD with an early age of onset. In this study, specific pathogenic mutations in the APP gene were introduced into an iPSC line from a healthy individual by the use of CRISPR-Cas9. The study resulted in the generation of two new cell lines, one carrying the V717I APP mutation and one with the KM670/671NL APP mutation.
Pubmed ID: 30634129 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets CD184 (CXCR4)
View all literature mentionsThis polyclonal targets Mouse IgG (H+L)
View all literature mentionsThis unknown targets
View all literature mentionsThis polyclonal targets Tuj1
View all literature mentionsThis polyclonal targets Alpha-1-fetoprotein
View all literature mentionsThis monoclonal targets CD34
View all literature mentionsThis monoclonal targets Human SSEA-4
View all literature mentionsThis unknown targets Human TRA-1-81 Antigen
View all literature mentionsThis monoclonal targets TRA-1-81
View all literature mentionsThis polyclonal targets Human Nanog
View all literature mentionsThis monoclonal targets SSEA-4
View all literature mentionsThis polyclonal targets POU5F1
View all literature mentionsThis monoclonal targets SSEA-3
View all literature mentionsThis monoclonal targets TRA-1-60-R
View all literature mentions